Mukka Proteins Plans Sri Lanka Subsidiary

Board Approves Sri Lanka Subsidiary

Mukka Proteins Ltd has announced its board has approved the incorporation of Lanka Bio Proteins Private Limited in Sri Lanka. This strategic move aims to bolster the company's presence in the marine products sector. Mukka Proteins plans to invest up to ₹2.50 crore for a 49% stake in the new subsidiary.

Strategic Rationale

This expansion marks Mukka Proteins' ambition to diversify its operations geographically and enter new markets beyond India. Strengthening its position in the global marine ingredients sector could open up new revenue streams and avenues for growth.

Company Background

Mukka Proteins Ltd is a key Indian manufacturer of fish oil, fish meal, and other marine-based ingredients for animal feed. The company recently completed its Initial Public Offering (IPO) in March 2024, with proceeds intended for working capital and expansion initiatives, including capacity enhancements.

Investment Details and Entity Capital

Mukka Proteins plans to invest up to ₹2.50 crore to acquire a 49% stake in Lanka Bio Proteins Private Limited. The new subsidiary is planned with a total capital of ₹3.60 crore and will focus on manufacturing and trading marine products. The incorporation of the Sri Lankan entity is targeted for completion by December 31, 2026.

Key Considerations and Next Steps

Successful establishment and operation in Sri Lanka will depend on regulatory approvals and market conditions. The December 31, 2026 completion target indicates a medium-term execution horizon. As the new entity is yet to be incorporated, it currently has no established turnover or financial history.

Other Indian marine ingredient companies, such as Avanti Feeds Ltd and Coastal Corporation Ltd, already possess global footprints with established export channels and international market presence.

Investors will be tracking the progress of securing necessary regulatory approvals, including those from the Reserve Bank of India (RBI) under FEMA. Official confirmation of Lanka Bio Proteins Private Limited's incorporation, along with updates on the market entry strategy and initial operational milestones, will also be key. The company's ability to manage execution risks and meet the target completion date will be closely watched.